The Farr Institute
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The Farr Institute is a UK-wide research collaboration involving 21 academic institutions and health partners in England, Scotland and Wales. Publically funded by a consortium of ten organisations led by the Medical Research Council, the Institute is committed to delivering high-quality, cutting-edge research using 'big data' to advance the health and care of patients and the public. The Farr Institute does not own or control data but analyses data to better understand the health of patients and populations.

The Farr Institute's researchers perform pioneering inter-disciplinary research with large and complex data. The Institute does not own or control data but analyses data to better understand the health of patients and populations. It develops skills, talent and expertise in the health informatics research community and provides tools for collaborative working. It has active groups working on public engagement, informatics methods, enabling new datasets and developing new infrastructure, technologies, and standards for health informatics research.

The Farr creates partnerships bringing together government, public sector, academia and industry to foster relationships and establish best practices for innovation, discovery. Its regulation and ethics specialists work with the owners and controllers of data to support the safe use of patient information for medical research across the UK, championing data protection, confidentiality and privacy.

The Farr Institute International Conference 2015
================================================

Ran from 26 -- 28 August 2015 at St Andrews, Scotland

The conference provided a vibrant and stimulating atmosphere to enhance global collaborations in the field of health informatics research. It built on the successful conferences under the auspices of SHIP attracting delegates from across the world including New Zealand, Australia, the United States, Canada and Europe.

The conference was for researchers, practitioners and policy makers interested in record linkage and the use of routine health data in their research. During the three-day programme, delegates attended a variety of plenary sessions, workshops and keynote speakers as well as networking opportunities.

Sessions were organized under the themes of Cohort Study Linkage, Research Methodology, Best Practice in Governance, Public Engagement, Stratified Medicine, Clinical Trials (Methodology and Execution), Open Innovation using Data Analytics and Data linkage to support Policy development.
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### Matched population-based study examining the risk of type 2 diabetes in people with and without diagnosed hepatitis C infection
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In Scotland in 2012, an estimated 37,000 people were living with chronic infection with Hepatitis C virus (HCV). People infected with chronic HCV have an increased risk of liver disease, especially when affected by co-morbidities. Meta-analyses have found HCV infection to be associated with an increased risk of type 2 diabetes mellitus (T2DM). Here, we examine this association within a large population-based study, according to chronic and resolved infection.

#### Methods:

An HCV-positive cohort was identified using data held at Health Protection Scotland. The HCV-positive cohort consisted of 21,929 people diagnosed with HCV between 1985 and 2011. 15,827 people in the cohort had chronic HCV and 3927 resolved HCV (2175 with unknown status). An HCV-negative cohort was then identified using data from the Community Health Index (CHI). For each person in the HCV-positive cohort, 3 people (in total 65,074 people) were selected from CHI matched on neighbourhood, sex and year of birth. A diagnosis date was attributed to each matched group, equal to the date of HCV diagnosis of the HCV-positive member. Both cohorts were then linked to a database holding information on over 300,000 people with diagnosed diabetes in Scotland. We followed up each cohort member through 3 time periods: up to one year before (*pre*-HCV) / within one year of (*peri*-HCV) / more than one year post (*post*-HCV) the date of HCV-diagnosis. Data were analysed in multivariate regression models including a random group effect.

#### Results:

T2DM had been diagnosed in 2.9% of the HCV positive cohort and 2.7% of the HCV negative cohort. A higher proportion of T2DM was diagnosed in the *peri*-HCV period (i.e. around the time of HCV-diagnosis) for the HCV positive cohort (22%) compared to the HCV negative cohort (10%). In both the *pre*-HCV and *post*-HCV periods, only those in the HCV positive cohort living in less deprived areas (13% of the cohort) were found to have a significant excess risk of T2DM compared to those in the HCV negative cohort (adjusted odds ratio (95% CI) in the *pre*-HCV period: 4.02 (2.32--6.96); for females and 2.33 (1.42--3.83) for males; adjusted hazard ratio in the *post*-HCV period: 1.53 (1.14--2.04)). These findings were similarly observed for both with chronic HCV and those with resolved HCV.

#### Conclusions:

In the largest study of T2DM among chronic HCV-infected individuals to date, there was no evidence to indicate that infection conveyed an appreciable excess risk of T2DM at the population level.
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### Ten-year risks of harm in adolescents hospitalised with violent, drug/alcohol-related, or self-inflicted injury: analysis of linked hospital and mortality data
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#### Background & Objective:

The hospitalisation of an adolescent for violent, drug/alcohol-related, self-inflicted injury provides opportunity to identify vulnerable individuals and intervene to reduce harm. However, there is a lack of evidence on the long-term risk of harm in this population. We used administrative hospital data linked to death records to determine long-term risks of death and emergency re-admission in these adolescents, and compared these risks to those following accident-related injury.

#### Methods:

We identified adolescents (10--19 year olds) in longitudinally-linked admissions data linked to death registrations for England (Hospital Episode Statistics, April 1997-March 2012), whose index emergency admission for injury was related to adversity (violence, drug/alcohol use, or self-harm) or an accident, defined using ICD-10 codes. We calculated Kaplan-Meier estimates of cumulative risks of death and emergency re-admission after discharge from the index admission and within ten years, by sex and age-groups (10--14 y, 15--17 y, 18--19 y). We estimated hazard ratios (HRs) of death and emergency re-admission following adversity-related injury (relative to following accident-related injury), adjusted for age-groups. We also estimated age-adjusted HRs of a second, third, fourth, and fifth emergency re-admission (\<5% had more than five).

#### Results:

Among 333,009 adolescents admitted with adversity-related injury, the risk of death by ten years was 7.3/1,000 (1 in 137) for girls and 15.6/1,000 (1 in 64) for boys; risks of emergency re-admission were 54.2% for girls and 40.5% for boys. All ten-year risks were higher in 18--19 year olds than in younger age-groups. Risks of death were increased after adversity-related injury when compared with those after accident-related injury (girls age-adjusted HR: 1.61; 95% confidence interval \[CI\]: 1.43 to 1.82; boys 2.13; 1.98 to 2.29), as were risks of emergency re-admission (girls age-adjusted HR: 1.76; 95% CI: 1.74 to 1.79; boys 1.41; 1.39 to 1.43). These risks were increased after all combinations of adversity-related injury, but particularly after any drug/alcohol-related or self-inflicted injury (i.e., with or without violent injury). Risks of repeat readmissions (i.e. of a second to fifth emergency re-admission) were also increased following adversity-related injury compared with accident-related injury (girls age-adjusted HR of a fifth emergency re-admission: 2.38; 95% CI: 2.29 to 2.46; boys 2.94; 2.81 to 3.07).

#### Conclusions:

Adolescents admitted to hospital for any violent, drug/alcohol-related, or self-inflicted injury are at increased risks of subsequent harm. Clinical guidelines and interventions for adolescents presenting with such injuries need to be developed to reduce these risks.

### Funding:

This work was supported by the Policy Research Unit in the Health of Children, Young People and Families (funding reference 109/00017), which is funded by the Department of Health Policy Research Programme.
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### Assessing the accuracy of patient-provided addresses

**Authors: Rodgers Sarah, Johnson Rhodri, Walters A. M., Fry R. J., Dsilva R. and Lyons R. A.**

Swansea University

**Presenting Author Sarah Rodgers**

email: <s.e.rodgers@swansea.ac.uk>

#### Introduction:

Linking environmental exposure to individual level health data is challenging but sometimes it is the only method of retrospectively evaluating health changes as a result of an intervention or natural experiment. This is particularly relevant for evaluating health outcomes as a result of non-NHS interventions, for example, changes as a result of regional economics or policy introduction. This could include changes in the number of harmful or health promoting facilities in the local environment; or improvement work to bring social housing up to national quality standards.

#### Method:

We have a system for capturing patient address updates through time, matching these to a national address system, and creating residential anonymised linking fields. Patient-provided addresses are the basis for extracting individual level health records for relevant exposure and follow up periods. We assessed the accuracy of routinely collected addresses against data collected from the individual in their home as part of an interview assessing for housing repairs.

#### Results:

We report that address data from a patient-provided routine data source are reliable when compared to interview data for a cohort of 80,000 mainly older individuals undergoing interview assessment for home improvements.

#### Conclusion:

The convenience sample of older adults, who would like to remain in their own home, provides a conservative estimate. Further work is needed to assess younger, more mobile population groups. The evaluation of patient-provided routine data against addresses collected during interviews is a useful first investigation into the accuracy of a patient-population routine data source.

### Funding:

We acknowledge support from The Farr Institute, supported by a 10-funder consortium: Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the Medical Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientist Office (Scottish Government Health Directorates), the Wellcome Trust, (MRC Grant No: MR/K006525/1). We also acknowledge the support of Care & Repair Cymru as data providers. This charitable organisation have allowed us to anonymise and link data collected by their staff from home owners in need of housing repairs and support.
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### Meaningful events from EHR prescription data
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#### Introduction:

Primary care research databases derived from EHRs contain coded prescription information. Much of this information is unstructured or unordered, and interpretation is required to assign clinical meaning to it. A common approach is to consider the dosage or presence of a drug as a single covariate, however, to contextualize prescribing to the clinical decisions made on care pathways it is necessary to convert the EHR data into events, such as when therapy is commenced, terminated or changed. These events are useful for: care pathway analysis; process mining; next-generation phenotyping; realistically-complex quality indicators; and audit. We focus on antihypertensive medications.

#### Method:

We used an anonymized extract of primary care data from 53 general practices in Salford, UK (population 234 k). All prescriptions of drugs recommended by NICE for the treatment of hypertension were extracted. We created a mapping between each drug code, the active ingredient(s) and the tablet dose (mg). We found 653 Read codes and 199 vendor-specific codes, covering 178 brand names and 70 generic names. Text mining, using regular expressions, on 216,101 distinct patient instructions yielded the number of tablets taken per day. We then iteratively developed an algorithm to take the amount, frequency, duration and type of medication to extrapolate events. Two authors (RW and BB, a clinician) independently reviewed a random sample of 100 patients to determine if the correct sequence of events had been extracted, with disagreements resolved through discussion.

#### Results:

The algorithm was developed over 6 iterations involving the examination of 179 patient records. 10,311,973 prescriptions were extracted for 81,096 patients between 1977 and 2014 (54% female, median age 64, IQR \[50, 77\]). The algorithm produced 850,028 events (28% starts, 34% stops, 15% restarts, 16% dose increases, 8% dose decreases, 0.02% unclassified). During validation the algorithm achieved a PPV of 92% (95% CI 85%--96%). Of the 100 records reviewed only 8 had incorrect sequences and these were still largely correct. Four missed a single stop event, two were false increases due to an erroneous prescription, one had an extra stop, and one misclassified a switch from 2.5 mg indapamide to 1.5 mg modified release (clinically identical) as a decrease.

#### Discussion:

We have developed a method for transforming unstructured EHR prescription data into clinically meaningful events on a care pathway. From these events we can determine: when a patient is taking medication; adherence issues; when an intervention is/isn\'t made by a physician; and when guidelines are followed correctly.

### Funding:

Funded by the National Institute for Health Research Greater Manchester Primary Care Patient Safety Translational Research Centre (NIHR GM PSTRC). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health.
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#### A tool to encourage ongoing participation in an online longitudinal study
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##### Background:

The UK MS Register gathers data from 3 sources; Clinicians, routine data and directly from people with MS via a web portal. Currently more than 11,000 participants are involved in the longitudinal study and asked to return quarterly to answer Patient Reported outcome Measure (PRoMS) questionnaires. As with all longitudinal studies attempting to keep participants engaged with the research is challenging.

##### Objective:

To categorise the responsiveness of participants answering PRoMS promptly and comprehensively to be monitored by the team and reported back to the participants to encourage them to keep participating.

##### Methods:

The participants were categorised so that activity could be monitored weekly. A SQL stored procedure was deployed calculating user activity from registration to present and then assigning states to users, these were; New user -- participant who has joined the Register in the last week.Registered Only -- participant who joined the Register more than a week ago, completed no questionnaires.Super Star -- participants who filled in their questionnaires including core ones within ten days of their email reminder.Very Active -- participants who return to fill in their questionnaires within three months of their email reminder.Active -- participants who return within 6 months to fill in their questionnairesHibernating- participants who have not completed any questionnaires for 6 months.

These categories were then displayed to the participants as a "Star-Bar". An email system was created to tell users their status and when to return back to the Register. These reminders were automated to try and keep people in the Super Star, Very Active and Active categories.

A web based visual chart was created to show the total number of users by state and the vectors between them eg Active participants to Hibernating. The interactive diagram and Star-Bar uses new JavaScript and HTML5 techniques.

##### Results:

Once categorised and email reminders sent out, a substantial number of previously inactive and potentially disengaged participants responded. This movement was clearly illustrated by the new instrument. The numbers in January 2013 before implementation of Platinum, Very Active and Active have increased measurably from a sum of 2567 to 3972.

##### Conclusions:

The tool is now used daily to monitor the effectiveness of marketing initiatives and new questionnaires to see if they engage with the users to participate. Results are used for management reporting. The automated emails have meant that retention to the study is higher, which results in richer data to link with.

#### Funding:

This work was supported and completely funded by the MS Society
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#### Data linkage to support a model of child cancer survivor care
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##### Background/Objectives:

Although more effective treatments and screening have led to increasing numbers of individuals surviving cancer, survivors may be at increased risk of long-term morbidity due to the cancer, treatment complications, or effect on existing comorbidities. High-quality evidence of late effects risks and their predictors, and risk-stratified models of survivor follow-up care, are needed for effective, efficient surveillance and management. Follow-up of adult-age childhood cancer survivors in British Columbia (BC) occurs mainly in the primary care setting, with little coordination and support. Results from a research program, linking clinical records of all child cancer cases diagnosed in BC from 1970 to mortality, cancer, and health administrative databases for up to 40 years, were used to inform recommendations for strategies and a model of care to meet ongoing healthcare needs of this survivor population.

##### Design/Methods:

Results from the BC Childhood, Adolescent, Young Adult Cancer Survivor Research Program were used in a needs assessment; evaluation of ongoing healthcare demand and costs; identification of gaps in care; and determination of the size and characteristics of subgroups requiring different levels of care.

##### Results:

There were approximately 3000 adult-age survivors. The number of survivors transitioning to adult-age care increased each year by 3%. Over 40% lived more than 70 km from the main pediatric hospital. The proportion of at-risk survivors receiving at least one recommended follow-up surveillance test ranged from 0.8% (thyroid-stimulating hormone) to 87% (complete blood count). By 20 years post-diagnosis, 20% of survivors had no conditions leading to hospitalization, and 35% had four or more types of these conditions. High users of later outpatient services included survivors of central nervous system (brain) tumours, bone sarcomas, and leukemia other than acute lymphatic leukemia; and those with previous cranial radiation, combination chemotherapy and radiation, combination surgery chemotherapy and radiation, and stem cell transplant. These data contributed to the development of risk-stratified models of care and a business case for implementation.

##### Conclusion:

Working group recommendations led to funding for a formal risk-tiered adult-age childhood cancer survivor follow-up program in BC. This original research demonstrates that population-based longitudinal database linkages of clinical and health administrative data provide high-quality evidence to inform the development of models of quality, sustainable, cancer survivor care, for both children and adults, that can improve health care policy and practice. This approach can inform oncologists, primary care providers, program managers and policymakers of cost-effective strategies for long-term surveillance and care.

#### Funding:

The CAYACS Research Program was supported by the Canadian Cancer Society (CCS) Research Institute (Program Project Grant\#19000) and the CCS BC & Yukon Division (PPG\#19804).
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#### Validity of self-reported parental hip fracture: a population-based parent-offspring record linkage study
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##### Introduction:

Multiple risk factors have been tested for their association with osteoporosis-related fracture, including parental hip fracture. This information is usually collected via self-report from offspring, a method potentially prone to recall bias. Our purpose was to test the validity of self-reported parental hip fracture using linked administrative health databases.

##### Method:

The study was conducted with population-based databases from Manitoba, Canada (population 1.2 million; public healthcare system), including hospital discharge abstracts, population registry files, and a unique province-wide bone mineral density (BMD) registry containing test results and clinical risk factors for fracture. The study cohort included individuals 40 + years with self-reported parental hip fracture information in the BMD registry between January 2006 and March 2013; BMD testing selection criteria emphasize screening for women ages 65+ and targeted testing in men and high-risk younger women. The population registry (1970 -- 2013) was used to identify parent-offspring clusters and dates of health insurance coverage; offspring whose parents did not have continuous health insurance coverage in the observation period were excluded. Diagnoses recorded with the International Classification of Diseases (ICD) in hospital discharge abstracts (1970 -- 2013) were used to ascertain parental hip fracture (ICD-8 N820; ICD-9-CM 820; ICD-10-CA S72.0-S72.2; all persons with hip fracture are hospitalized). Sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and kappa (κ; \>0.60 indicates substantial agreement) were estimated.

##### Results:

We identified 7,359 offspring in the BMD registry with parental information; 12.2% reported a parental hip fracture. Mean offspring age was 52.5 years (SD 5.7) and 85.7% were female. Self-report sensitivity was 0.69 (95% confidence interval \[CI\] 0.67, 0.72), specificity was 0.96 (95% CI 0.96, 0.97), PPV was 0.76 (95% CI 0.73, 0.79), NPV was 0.95 (95% CI 0.95, 0.96), and κ was 0.68 (95% CI 0.66, 0.71). There was 92.9% overall agreement between self-report and administrative data. Sex-stratified analyses produced sensitivity for males of 0.57 (95% CI 0.49, 0.64) and for females of 0.72 (95% CI 0.69, 0.75); for males κ was 0.62 (95% CI 0.54, 0.69) and for females it was 0.70 (95% CI 0.67, 0.72). Sensitivity was lowest for 40--44 years (0.65; κ = 0.56) and highest for 55--59 years (0.72; κ = 0.69).

##### Conclusions:

Offspring self-reported parental hip fracture exhibited very good to substantial agreement with diagnoses in administrative health data. The unique record linkage capabilities in Manitoba presents a number of opportunities for including parental health history in offspring disease risk prediction.

#### Funding:

This research was supported by funding from Research Manitoba to LML.
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### Abstract 1527

#### Diagnosing AKI in routine healthcare -- why the definition matters
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##### Background:

Acute kidney injury (AKI) is a serious condition complicating 1 in 7 hospital admissions. It coexists with severe illness and can happen in any clinical setting, so all clinicians must be aware of AKI. A true diagnosis of AKI is clinical, incorporating rapid changes in blood tests (serum creatinine) and urine output. Unfortunately, recognition and care in AKI is often delayed leading to preventable harm. Initiatives to improve its timely diagnosis include automated AKI alerts to clinicians when serum creatinine changes suggest AKI.

World Health Organisation International Classification of Disease (ICD-10) codes for diagnosis are also routinely collected in the UK for use in healthcare planning. They rely on both clinical recognition and subsequent recording on hospital discharge. Based on ICD-10 recording, the incidence of AKI is believed to be rising. This has implications for healthcare planning, but current evidence from ICD-10 recording may reflect increased clinical recognition rather than true changes.

This analysis explores the implications of these three methods commonly used to define AKI in research -- clinical diagnosis, automated creatinine algorithms, and ICD-10 coding.

##### Methods:

We used the NHS England automated AKI detection algorithm to identify AKI using all serum creatinine results in Grampian, 2003--2008 (adult population ∼450,000). We compared the estimated annual incidences of AKI using automated detection with the mid-year Grampian populations and blood testing practices over 2003--2008. We collected ICD-10 AKI coding and compared this with automated AKI detection. Finally, we used a subgroup of 4464 patients with renal impairment characterised by nephrologist review of case-notes to provide a comparison with the clinical diagnosis.

##### Results:

From 2003 to 2008 the adult population of Grampian rose 6% and serum creatinine testing rose 26%. By automated AKI detection, the annual incidence of AKI also rose 14% from 5565 to 6359, but was unchanged after accounting for the rise in population and blood testing practices. In contrast, over the same period ICD-10 AKI recognition rose almost twofold.

ICD-10 AKI was a minority of all automated AKI detection cases (6%), but a greater proportion of the most severe (stage 3) automated detection cases (28%). Against case-note review, automated detection did identify patients with a definite clinical diagnosis, but also included patients without AKI (20%) and with an uncertain diagnosis (29%).

##### Conclusions:

Apparent increases in the incidence of AKI can in part be explained by increased testing and recognition. Different definitions select a different AKI case-mix and this requires careful thought when planning and interpreting AKI clinical research.

#### Funding:

We acknowledge the data management support of Grampian Data Safe Haven (DaSH) and the associated financial support of NHS Research Scotland, through NHS Grampian investment in the Grampian DaSH. SS is supported by a Clinical Research Training Fellowship from the Wellcome Trust (Ref 102729/Z/13/Z). We also acknowledge the support from The Farr Institute of Health Informatics Research. The Farr Institute is supported by a 10-funder consortium: Arthritis Research UK, the British Heart Foundation, Cancer Research UK, the Economic and Social Research Council, the Engineering and Physical Sciences Research Council, the Medical Research Council, the National Institute of Health Research, the National Institute for Social Care and Health Research (Welsh Assembly Government), the Chief Scientist Office (Scottish Government Health Directorates), the Wellcome Trust, (MRC Grant Nos: Scotland MR/K007017/1). The funders of this study had no role in study design; collection, analysis, and interpretation of data; writing the report; and the decision to submit the report for publication.
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#### Using a novel Bayesian approach to probabilistically link records in the ECFSPR
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##### Background:

Patient registries are essential for outcome analysis, particularly in rare diseases. Such data are mostly collected as annual snapshots. Records from individual patients must then be amalgamated using a unique identifiers to understand the longitudinal progress of the patients across years. Such identifiers are often not available when data are collated across countries and hence a robust method of record linkage is required. Here, we apply astronomical techniques to solve this pressing problem, using an international CF registry as a paradigm.

##### Methods:

We adopted a hierarchical Bayesian partition model framework, developed in astronomy, to probabilistically link patient records in the European Cystic Fibrosis Society Patient Registry (ECFSPR) using gender, genotype, diagnostic age, body mass index and height as factors. We applied our method to CF patient data held in Denmark for which pseudonimised identifiers were provided but personalised identifiers withheld.

##### Findings:

Our algorithm correctly linked the records belonging to the same patients, (with TPR = 99.5\\% FPR = 0.5\\% for all probability thresholds and a ROC score of 0.97). We serendipitously discovered data errors in the pseudonimised identifiers, some of which were unknown to the registry administrators in the ECFS. Our algorithm is capable of providing an accurate probability of whether a pair of records belong to the same patient or whether preexisting pseudonimised identifiers are actually correct.

##### Interpretation:

Our approach could reassemble legacy data sets where there is no likelihood of linkage information becoming available. We demonstrate that unique identifiers, although essential for clinical purposes within a hospital setting, might not always be accurate across years and provide an automated approach to pseudonomise data enabling reconstruction of large data sets across time.
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##### Background:

Farr Scotland is creating a national research dataset from imaging data contained in the national clinical PACS (Picture Archive and Communication System). This contains all clinical radiological imaging captured across Scotland since 2006, and therein a wealth of untapped phenotypic data. It is believed this will be the largest resource of its kind in the world.

The project leverages the Health Informatics Centre (HIC) Research Data Management Platform (RDMP), extending it with the capability to manage large-scale image data.

##### Aims:

Enable novel research by providing a linkable, research-ready radiological imaging dataset and image analysis tools in a Safe Haven environment.Provide workflows and infrastructure for \'big data\' analysis of imaging through co-location with an HPC resource.Develop a general imaging data extension to the HIC RDMP to be used as the basis for managing other imaging datasets.

##### Methods:

Creating a large-scale repository of unconsented clinical imaging data involves significant challenges beyond those encountered with text-based electronic records. There are technical challenges related to the sheer volume of data, but there are also significant challenges around anonymisation, governance and security. With 700TB of data, increasing at approximately 20TB/month, any solution requires not only adequate storage for the dataset and project extractions but network, infrastructure and management software with sufficient throughput to keep pace with the influx of new imaging. This talk will discuss these challenges and the solutions that have been devised and implemented.

There are further challenges in extracting sufficiently rich metadata for useful cohort identification, and the potential for creating new metadata through automatic analysis of the pixel data and DICOM tags. This talk will examine these and other researcher-oriented challenges including data extraction and analysis tool provision in the Safe Haven environment.

##### Results:

Solutions for the historic and ongoing transfer processes have been developed, with 120TB of historic data currently saved. The logical software architecture for the system at the Advanced Computing Facility has been created and software components have been implemented, including a robust caching mechanism and a DICOM file-specific load module for the RDMP Data Load Engine.

##### Conclusions:

This project will unlock a whole new class of data for researchers to use in large-scale linkage studies, supplying both the data and tools with which to perform novel research that has not been possible before now, and could have wide-ranging benefits for public health both in Scotland and beyond.
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##### Background and Objective

Dementia has catastrophic implications for affected individuals, their family and wider society. Combining information about genes with detailed clinical information in large populations provides a powerful way of investigating why people vary in susceptibility to dementia and how they will respond to treatments. However, patients with dementia are challenging to study because their diagnoses are not easily observable in the electronic medical records (EMRs) and so are greatly underrepresented in large population-based bioresources. The objective of this study was not only to develop a heuristic phenotype algorithm to identify patients who have developed dementia since being recruited into the large Genetics of Diabetes Audit and Research in Tayside Study (GoDARTS) bioresource, but also to use established genetic instruments for validation of the phenotype.

##### Methods:

A heuristic phenotype selection algorithm was applied iteratively on five selected datasets (i.e. General Registrar Office -- Death Certification (GRO), Prescribing, and Scottish Morbidity Records: SMR00, SMR01, and SMR04) from the GoDARTS bioresource. Available genomic data was linked to EMR for the GoDARTS\' participants using the HIC Research Data Management Platform (RDMP). Cox proportional hazards' models were constructed to estimate the risk of dementia association with the apolipoprotein E epsilon 4 (ApoE4) single nucleotide polymorphism (SNP) and a weighted Genetic Risk Score (wGRS), calculated using 20 known susceptibility SNPs associated with Alzheimer's disease.

##### Results:

The algorithm identified 855 definite cases of dementia from the GoDARTS population of 18,190. Amongst the 855 dementia cases identified, 446 individuals were found to be genotyped for both the ApoE4 and the wGRS SNPs. In a Cox regression model involving age and gender as covariates, the study demonstrated that the ApoE4 (Hazard Ratio (HR) = 1.98; 95% Confidence Interval (CI): 1.59--2.46; *p-*value = 1.01 × 10^−9^) and the wGRS (HR = 1.63; 95% CI: 1.14--2.32; *p-*value = 7.04 × 10^−3^) were independently associated with dementia, with non-statistically significant gender differences. The combined model of the wGRS and the ApoE4 also indicated a significant association with dementia (HR = 2.13; 95% CI: 1.60--2.84; *p-*value = 2.31 × 10^−7^), with non-statistically significant gender differences. The overall incidence rate of dementia in the GoDARTS bioresource was found to be 7.28 per 1000 person-years.

##### Conclusion:

The study demonstrates that it is possible to identify patients with dementia from large population-based bioresources using genetic instruments for validation. Such an approach can generate a dementia specific sub-cohort for the international research community to support translational research.
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### Ambulatory care data in a stable chest pain cohort (n = 8762): prognostic modeling of 10 year coronary mortality
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#### Objective:

Ambulatory care data in the hospital setting are rarely available for clinical research. We recorded clinical data in patients referred for outpatient assessment of chest pain and then followed them up for 10 years. The study objectives were to develop a new prognostic model to inform clinical management and to determine relations between mortality risk and the probability of coronary disease utilising modified Diamond-Forrester and Duke score estimates.

#### Methods and Results:

In a multicenter study, clinical data were recorded electronically in 8762 ambulatory patients attending for cardiac outpatient assessment of previously undiagnosed chest pain. The patients were followed-up in the linked national death registry for a median 10 years (minimum 9 years) during which 233 coronary deaths were recorded. A prognostic model was developed with internal validation showing strong association with 10 year mortality for age, sex and chest pain typicality as well as ethnicity, pulse rate, smoking status, diabetes and ECG findings. Model discrimination was good (Harrel's c = 0.83), patients in the highest risk quartile accounting for 173 coronary deaths during follow-up compared with a total of 60 deaths in the lower risk quartiles. Observed 10 year coronary mortality increased progressively as the predicted risk of coronary disease by the Duke score increased, ranging from 0.2% to 25.4% in patients with predicted risks of coronary disease \<10% and \>90%, respectively. Only in groups with a ≥30% predicted risk of coronary disease did the observed 10 year coronary mortality exceed 1%.

#### Conclusion:

For the first time in ambulatory patients with suspected angina, a prognostic model is presented based on simple clinical factors available at the initial cardiac assessment. The model discriminated powerfully between patients at high risk and at lower risk of coronary death during the follow-up period. Its potential clinical utility was reflected in the prognostic value it added to probability estimates of coronary disease by the Duke score.
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##### Background:

In this paper we present a sub-section of findings from an evidence review commissioned by the Nuffield Council on Bioethics (NCOB) *Working Party on Biological and Health Data* and the Wellcome Trust's *Expert Advisory Group on Data Access* (EAGDA), entitled *Review of evidence relating to harms resulting from security breaches or infringements of privacy involving sensitive personal biomedical and health data*. A multi-disciplinary piece of work, this paper reports from the fields of Law and Social Psychology.

##### Purpose:

One of the review's purposes was to allow the NCOB and EAGDA to better understand the nature of the 'actual harms' resulting from data misuse or security breaches. However, we contend that 'actual harm' as understood in the legal context cannot be extrapolated to the psychosocial context, because here subjectivity is the key. Therefore we distinguish between 'harm' (legal) and 'impact' (psychosocial), the latter ranging from none at all, to mild irritation, to extreme distress.

##### Method:

Given the expansive remit, this was a scoping exercise. (1) Systematic searches were undertaken to establish 'hard evidence' (UK Case Law; ICO) and from Twitter, and a narrative search in the grey literature (newspapers, NGOs). (2) Where possible, each piece of evidence was examined to establish the type of breach/misuse and cause of abuse, and the resultant harm/impact. (3) Findings were noted in a matrix and then triangulated to compare and contrast evidence from each source.

##### Results:

We identified 51 pieces of hard evidence, 77 pieces from Twitter and 57 from the grey literature. We compare and contrast our findings in this paper.

##### Discussion:

Based particularly on the grey literature-based evidence, it is clear that several factors need to be considered if we are to shed light on what harm and distress can mean in social reality terms, and if and how subjects can be protected, supported and, perhaps, compensated. There are limits in how the law recognises and compensates for harms. In context of data processing, legal redress is typically contingent on causal connection to an economic loss. This neglects the broader spectrum of impacts that the psychosocial dimension elucidates. Earlier and closer attention must be paid to identify the range of interests at stake when processing biological and health data, including risks and benefits involved with a proposed use of data. We propose more explicit engagement with all population groups and an enacted recognition of their sensitivities within governance mechanisms.
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#### Background:

The CRUK Stratified Medicine Programme aimed to address the challenges of implementing stratified medicine into the NHS. Working with 28 hospitals and 3 laboratories across the UK, the programme tested large volumes of samples for multiple markers and captured the associated molecular and clinical data for use by researchers.

#### Method:

The clinical request and molecular information was transferred in XML (extensible markup language) format via a secure file transfer protocol. Upon receipt of the molecular results, 100 data items were added including demographic, treatment and outcome data using the Cancer Outcomes and Services dataset information standard. For the molecular data, Human Genome Variation Society approved nomenclature was agreed as standard. Sites chose a combination of automated and manual data collection approaches. Monthly data uploads were sent to the National Cancer Registration Service -- Eastern Office.

#### Results:

Over 8000 unique datasets were collected from the clinical records of consented patients. Data quality and completeness improved through regular analysis, reporting, feedback and resolution of issues. Although defined attributes were set, the data proved heterogeneous between individual patients and geographical sites, representing the use of different terminology and coding systems. For example in the first data review of 4,204 records for TNM (tumour, nodes metastasis) staging, 336 different forms of staging data were recorded and of 13 possible attributes for Cancer Imaging Modality, 37 variations were observed. Analysis of the molecular data showed variation in how mutations were described complicating aggregated analysis and requiring manual curation. Despite their key role in multidisciplinary team discussion, stage of disease, performance status and co-morbidity scoring were challenging to obtain as they were not captured in existing systems or stored as blocks of texts. Integrated TNM staging had 40.6% completeness across the programme, 99.8% in a site with dedicated manual resources and 32.8% at a site with an automated approach.

#### Conclusion:

Use of and adherence to information standards, application of validation rules and regular review of the data is crucial in providing high quality data amenable to aggregated analysis in a combined dataset. Close relationships with clinical teams is critical in identifying data sources and providing clarity on relevant data items for research. Fully integrated electronic patient records provide an effective, scalable and cost-effective mechanism of data capture but until this is achieved, dedicated data management staff are essential to source and collate data from different systems. Alternative approaches being explored include use of natural language processing.
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#### Using data linkage to evaluate rates of acute kidney injury and *Clostridium difficile* infection following a change in orthopaedic prophylactic antibiotic policy
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##### Background:

Prophylactic antibiotics are used in orthopaedic surgery to reduce rates of surgical site infections. Following a change in national antibiotic policy within NHS Scotland aimed at reducing *Clostridium difficile* infections (CDI), there was evidence that a regimen of flucloxacillin and gentamicin in orthopaedic patients was associated with a significant increase in acute kidney injury (AKI). As a result, the national antibiotic policy recommendation for orthopaedic surgical prophylaxis in Scotland, was changed from flucloxacillin and gentamicin to co-amoxiclav. Patients undergoing a neck of femur (NOF) repair received co-amoxiclav throughout the study period. This study aimed to assess whether this change in orthopaedic antibiotic prophylaxis policy was associated with changes in the rates of post-operative AKI and CDI in adult patients undergoing orthopaedic surgery.

##### Methods:

An observational cohort study was performed, assessing the rates of AKI and CDI among patients who had undergone orthopaedic surgery. Data were linked through the Health Informatics Centre, University of Dundee between the following datasets: Scottish Morbidity Record of hospital admissions, OPCS-coded procedures, laboratory results, medicines dispensed by community pharmacies, General Register Office death database and Scottish Care Information -- Diabetes Collaboration. 14,563 adults aged ≥18 years who resided, or died, in the NHS Tayside region and who underwent an orthopaedic surgical procedure between October 1, 2008, and December 31, 2013 were included in the analaysis. Interrupted time series (ITS) was used to assess rates of AKI over the time period of October 2008 to May 2012 when flucloxacillin and gentamicin was used compared with June 2012 to 2013, when the policy was changed to co-amoxiclav. Cases were split into two groups, NOF operation group and other orthopaedic surgeries group.

##### Results:

ITS analyses showed that 18 months following the change in policy there was a statistically significantly relative decrease in rates of all AKI by −63% (95% CI −77%,−49%) in the other orthopaedic surgeries group. The incident rate ratio (95% CI) of CDI was 0.29 (0.09 to 0.96).

##### Conclusion:

The change in orthopaedic antibiotic prophylaxis policy to co-amoxiclav led to reduced rates of AKI compared to the previous policy of flucloxacillin and gentamicin and was not associated with an increased rate of CDI.
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#### Introduction:

There is a consensus that birthweight is associated with cognitive abilities in childhood but it is unclear whether this association persists into adulthood. In this study we examine the relationship between birthweight and cognitive functions from childhood to mid-life based on the repeated measures (at ages 7, 9, 11 and 51--61 years) available through the linkage performed between the Aberdeen Children of the 1950s study (ACONF) and the Generation Scotland: Scottish Family Health Study (GS:SFHS) ("ACONF-GS:SFHS"; n = 558).

#### Methods:

Childhood cognitive ability was tested within six months of the child's 7th (n = 494), 9th (n = 491) and 11th birthdays (n = 414) \[Moray House Picture Intelligence; Schonell&Adams Essential Intelligence Test Form; Moray House verbal reasoning tests I/II, Moray House English and Moray House Arithmetic respectively\]. All tests were standardized for age. Mid-life cognitive functions were assessed with Verbal Fluency (n = 447), Mill Hill Vocabulary (n = 445), and Logical Memory Delay (n = 446). Birthweight in lbs (transformed to kg), father's occupation at birth, and mother's age at birth were abstracted from the Aberdeen Maternity and Neonatal Databank. Birth orders were self-reported. The statistical method was based on the study reported in Richards et al., 2001: birthweight was split into five categories \[BW \< 2.49 kg ("low"); 2.49 kg ≤ BW \< 3.18 kg ("normal-lower"); 3.18 kg ≤ BW \< 3.63 kg ("normal-middle"); 3.63 kg ≤ BW \< 4.08 kg ("normal-higher"); BW ≥ 4.08 kg ("high")\]. The analytical subsample had complete information on birthweight and confounders (father's occupation, mother's age, birth order, mid-life age). The associations between birthweight grouped into five categories and cognitive functions at every age were examined with linear regression.

#### Results:

Overall, 89% of ACONF-GS:SFHS participants (240 men, 318 women; mean age = 57.4) had birthweight within normal range. About 57% had a father in skilled/semi-skilled manual occupation and 33% completed higher/professional education. In the analytical sample, "low" birthweight was negatively associated with childhood cognition at age 7 compared with "normal-middle" birthweight (β = −8.92, SE = 3.64, p = 0.015). "Normal-higher" birthweight was positively associated with childhood cognition at age 7 compared with "normal-middle" birthweight (β = 3.78, SE = 1.75, p = 0.031). No other significant associations have been found. However, the expected pattern of associations was found only in mid-life (i.e. increasing mean cognitive function for the first four birthweight categories and decreasing for "high" birthweight).

#### Conclusion:

Our preliminary analysis indicates that birthweight might not have long-term effects on cognitive functions as shown in Richards et al., 2001. Next, we will examine the association between birthweight, gestational age, and cognition over the life-course.
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